关注
Rachael L. DiSantostefano
Rachael L. DiSantostefano
Senior Director, Epidemiology, Janssen Pharmaceuticals, LLC
在 its.jnj.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD)
JK Quint, H Müllerova, RL DiSantostefano, H Forbes, S Eaton, JR Hurst, ...
BMJ open 4 (7), e005540, 2014
2562014
Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma
HS Nelson, G Bensch, WW Pleskow, R DiSantostefano, S DeGraw, ...
Journal of allergy and clinical immunology 102 (6), 943-952, 1998
2361998
Reporting formative qualitative research to support the development of quantitative preference study protocols and corresponding survey instruments: guidelines for authors and …
IL Hollin, BM Craig, J Coast, K Beusterien, C Vass, R DiSantostefano, ...
The Patient-Patient-Centered Outcomes Research 13, 121-136, 2020
1472020
Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort
RL DiSantostefano, D Hinds, H Van Le, NC Barnes
Respiratory medicine 112, 88-96, 2016
902016
Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study
RL DiSantostefano, T Sampson, HV Le, D Hinds, KJ Davis, ND Bakerly
PLoS One 9 (5), e97149, 2014
642014
An evaluation of the economic costs and patient‐related consequences of treatments for benign prostatic hyperplasia
RL Disantostefano, AK Biddle, JP Lavelle
BJU international 97 (5), 1007-1016, 2006
642006
Is Johnny wheezing? Parent–child agreement in the childhood asthma in America survey
KJ Davis, R Disantostefano, DB Peden
Pediatric Allergy and Immunology 22 (1‐Part‐I), 31-35, 2011
632011
Gay Identification and Psychological Health in HIV‐Positive and HIV‐Negative Gay Men1
J Leserman, R DiSantostefano, DO Perkins, DL Evans
Journal of Applied Social Psychology 24 (24), 2193-2208, 1994
571994
Identification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysis
DR Hinds, RL DiSantostefano, HV Le, S Pascoe
BMJ open 6 (6), e010099, 2016
562016
The long-term cost effectiveness of treatments for benign prostatic hyperplasia
RL DiSantostefano, AK Biddle, JP Lavelle
Pharmacoeconomics 24, 171-191, 2006
532006
Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis
RL DiSantostefano, H Li, D Hinds, DV Galkin, DB Rubin
International journal of chronic obstructive pulmonary disease, 457-468, 2014
382014
Appraising patient preference methods for decision-making in the medical product lifecycle: an empirical comparison
C Whichello, B Levitan, J Juhaeri, V Patadia, R DiSantostefano, CA Pinto, ...
BMC medical informatics and decision making 20, 1-15, 2020
362020
Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis
RL DiSantostefano, H Li, DB Rubin, DA Stempel
BMJ open 3 (4), e001838, 2013
352013
Longitudinal study of social support and social conflict as predictors of depression and dysphoria among HIV‐positive and HTV‐negative gay men
J Leserman, R Disantostefano, DO Perkins, C Murphy, RN Golden, ...
Depression 2 (4), 189-199, 1994
331994
Special applications of pharmacoepidemiology
following individuals contributed to writing sections of this chapter:, D Lee, ...
Textbook of pharmacoepidemiology, 337-406, 2013
222013
Changes in asthma insights and reality in Japan (AIRJ) in 2005 since 2000
M Adachi, K Ohta, A Morikawa, S Nishima, S Tokunaga, ...
Arerugi=[Allergy] 57 (2), 107-120, 2008
212008
Ecologic analysis of asthma-related events and dispensing of inhaled corticosteroid-and salmeterol-containing products
RL DiSantostefano, KJ Davis, S Yancey, C Crim
Annals of Allergy, Asthma & Immunology 100 (6), 558-565, 2008
192008
Quantitative benefit–risk assessment: state of the practice within industry
MY Smith, J van Til, RL DiSantostefano, AB Hauber, K Marsh
Therapeutic Innovation & Regulatory Science 55, 415-425, 2021
162021
Chronic respiratory disease, comorbid cardiovascular disease and mortality in a representative adult US cohort
DM Mannino, KJ Davis, RL DiSantostefano
Respirology 18 (7), 1083-1088, 2013
162013
Something is better than nothing: the value of active intervention in stated preferences for treatments to delay onset of Alzheimer's disease symptoms
FR Johnson, RL DiSantostefano, JC Yang, SD Reed, J Streffer, B Levitan
Value in Health 22 (9), 1063-1069, 2019
152019
系统目前无法执行此操作,请稍后再试。
文章 1–20